What we do Parmax Pharma Ltd manufactures active pharmaceutical ingredients and provides contract manufacturing services, focusing on antibiotics like amoxicillin, ampicillin, and cephalexin. |
Founded in 1,994 |
Market share A niche player in antibiotic APIs with growing operational scale but currently operating below profitability. |
Problem solved Produces bulk drugs and APIs essential for antibiotic formulations, supporting pharmaceutical supply chains. |
Top clients or who we serve Pharmaceutical companies requiring antibiotics APIs, focusing on B2B contract manufacturing. |
Key management - |
Our journey and innovations Started in 1994 as a bulk drug manufacturer; implemented antibiotic projects in 1997; recovered from operational hiatus. |
Where we operate Primarily India; exports and other geographies not specified. |
Top products or what we offer Antibiotic APIs like amoxicillin trihydrate, ampicillin trihydrate, cephalexin monohydrate, and nalidixic acid. |
Top brands - |
Raw materials needed Raw materials for antibiotic API synthesis including chemical precursors for amoxicillin and related compounds. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue largely depends on periodic contract manufacturing orders; cyclical with potential recurring contracts. |
Our industry position Mid-sized pharmaceutical API manufacturer focused on antibiotics with potential to scale up production capacity. |
Financial highlights FY25 Revenue Rs. 28.2 crores; Net loss Rs. 2.09 crores, improved from previous year losses. |
Geographical revenue split - |
Order book - |
Whats driving growth Increased operational activity post-recovery and higher demand for antibiotic APIs. |
Our future plans Expand production capacities, complete insurance claims for factory damages, and improve financial performance. |
Our green promise - |
Our people and values Committed workforce focused on sustainable, safe pharmaceutical manufacturing. |
Key challenges ahead Recovering from fire damage, complying with regulatory norms, and achieving profitability. |
Interesting facts Incorporated in 1994 with roots in antibiotic bulk drug manufacturing, continuously evolving in pharma ingredients. |
Risks and strategy Managing operational setbacks, regulatory compliance, and market demand fluctuations; strategy focuses on cost control and client expansion. |
